CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012 at 4:15 p.m. ET at the Loews Miami Hotel, Florida.
